-
Mashup Score: 0
Larry Ereshefsky, PharmD, discussed the effects of brilaroxazine on inflammatory cytokines and neuroinflammation and how this can impact future schizophrenia treatment.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
In an interview, Larry Ereshefsky, PharmD discussed the safety profile of #brilaroxazine for #schizophrenia assessed in the #RECOVER trial. https://t.co/VpMcnSS4bq https://t.co/QilV3bUhVC